வெளிப்படையான குங் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வெளிப்படையான குங். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வெளிப்படையான குங் Today - Breaking & Trending Today

Were Hedge Funds Right About ASLAN Pharmaceuticals Limited (ASLN)?


Were Hedge Funds Right About ASLAN Pharmaceuticals Limited (ASLN)?
Is ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. The top picks of these firms have historically outperformed the market when we account for known risk factors, making them very valuable investment ideas.
ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) has experienced an increase in hedge fund interest recently. ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) was in 18 hedge funds’ portfolios at the end of March. The all time high for this statistic was previously 5. This means the bullish number of hedge fund positions in this stock currently sits at its all time high. There were 5 hedge funds in our database wi ....

Jim Cramer , Jonathan Barrett , Frank Kung , Albert Cha , Paul Segal Luminus , Xinyuan Real Estate Co Ltd , San Juan Basin Royalty Trust , Pharmaceuticals Limited , Orion Group Holdings Inc , Xtant Medical Holdings Inc , Ivy League , Yumanity Therapeutics Inc , Heat Biologics Inc , Evans Bancorp Inc , Nathaniel August , Insider Monkey , Good Stock To Buy , Vivo Capital , Orbimed Advisors , Arsani William , Logos Capital , Mangrove Partners , Paul Segal , Luminus Management , Med Advisors , Heat Biologics ,

Vivo Capital and an Investor Syndicate Completes Sale of Surgical Specialties Corporation to GTCR-ba


Search jobs
01-Feb-2021
Vivo Capital and an Investor Syndicate Completes Sale of Surgical Specialties Corporation to GTCR-backed Corza Health
PALO ALTO, Calif. (BUSINESS WIRE) Vivo Capital, a global healthcare investment firm, announced today that it has closed the sale of Surgical Specialties Corporation (“SSC”) to Corza Health, a portfolio company of GTCR, a global private equity firm.
Vivo Capital and an investor syndicate including certain Vivo limited partner co-investors acquired SSC, a global manufacturer and leader in the medical device consumables segment, in 2017. Since then, SSC has acquired three companies, divested one product line to Angiodynamics, and built two factories in the US and China while reinvigorating the company’s iconic brands, including Quill™ and Sharpoint™. ....

United States , Palo Alto , Shan Fu , Frank Kung , Latham Watkins , Dan Croteau , Piper Sandler , Corza Health , Vivo Fund , Surgical Specialties Corporation , Vivo Capital , Managing Partner , ஒன்றுபட்டது மாநிலங்களில் , பாலோ ஆல்டோ , ஷான் ஃபூ , வெளிப்படையான குங் , லாதம் வாட்கின்ஸ் , டான் சிரோட்டானு , பைபர் சாண்ட்லர் , விவோ நிதி , அறுவை சிகிச்சை சிறப்பு நிறுவனம் , விவோ மூலதனம் , நிர்வகித்தல் கூட்டாளர் ,

Vivo Capital Appoints New Managing Partners and Partners


Vivo Capital Appoints New Managing Partners and Partners
News provided by
Share this article
Share this article
PALO ALTO, Calif., Jan. 11, 2021 /PRNewswire/  Vivo Capital, LLC, a leading global healthcare investment firm, is pleased to announce the appointments of Dr. Hongbo Lu, Mr. Jack Bech Nielsen, and Mr. Michael Chang to Managing Partners.  The Firm is also promoting Ms. Cinthia Sheu, Chief Operating Officer, and Ms. Zhanping Wu, General Counsel, to Partners within the management company.
Dr. Frank Kung, Co-Founder, Managing Partner, and Chairman of Vivo, said: Hongbo is a remarkably talented investor whom we have known and collaborated with for more than ten years, and we couldn t be more thrilled to welcome her to Vivo.  We look forward to her playing a critical role in the Firm s investments in innovation and public equity globally.  She will also serve as the Chief Investment Officer for Vivo in China.  Jack and Michael have contributed tremend ....

United States , Palo Alto , Edgar Engleman , Cinthia Sheu , Jack Bech Nielsen , Michael Chang , Zhanping Wu , Frank Kung , Katera Mujadidi , Hongbo Lu , Novo Nordisk , University Of California , Reata Pharmaceuticals , Technical University , Harvard Business School , Haas School Of Business , Masters In Management Of Technology , University Of Washington , Vivo Capital , Harvard College , Tsinghua University , Piper Jaffray Co , Crinetics Pharmaceuticals , Technical University Of Denmark , Chief Operating Officer , General Counsel ,